SUNNYVALE, CA-- Medical device company Spiracur said it raised $35 million in new funding.
The Sunnyvale company has developed what it calls an “ultraportable and single-use, negative pressure wound therapy device.”
The round was led by a new investor, New York-based Maverick Capital.
Funding was also provided by new investor Pinnacle Ventures, which is based in Palo Alto; and existing investors De Novo Ventures, Kleiner Perkins Caufield & Byers and New Leaf Venture Partners, which all have offices in Menlo Park.
Read more: Spiracur gets $35M for wound-care system | Silicon Valley / San Jose Business Journal
